AR008083A1 - Composiciones farmaceuticas y el uso de compuestos para preparar medicamentos para tratar desordenes del snc. - Google Patents
Composiciones farmaceuticas y el uso de compuestos para preparar medicamentos para tratar desordenes del snc.Info
- Publication number
- AR008083A1 AR008083A1 ARP970103348A ARP970103348A AR008083A1 AR 008083 A1 AR008083 A1 AR 008083A1 AR P970103348 A ARP970103348 A AR P970103348A AR P970103348 A ARP970103348 A AR P970103348A AR 008083 A1 AR008083 A1 AR 008083A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- pharmaceutical compositions
- cns disorders
- treat cns
- prepare drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se refiere a composiciones farmacéuticas en base a combinaciones de compuestos que tienen actividad antagonista de 5HT2c y de D2, compuestos quetienen actividad en los dos receptores, y su uso para la manufactura de un medicamento en eltratamiento de la esquizofrenia.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9615767.2A GB9615767D0 (en) | 1996-07-26 | 1996-07-26 | Novel treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008083A1 true AR008083A1 (es) | 1999-12-09 |
Family
ID=10797573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970103348A AR008083A1 (es) | 1996-07-26 | 1997-07-24 | Composiciones farmaceuticas y el uso de compuestos para preparar medicamentos para tratar desordenes del snc. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0936924A2 (es) |
| JP (1) | JP2000516924A (es) |
| KR (1) | KR20000029564A (es) |
| CN (1) | CN1230894A (es) |
| AR (1) | AR008083A1 (es) |
| AU (1) | AU725817B2 (es) |
| BR (1) | BR9710568A (es) |
| CA (1) | CA2261813A1 (es) |
| CO (1) | CO5031292A1 (es) |
| CZ (1) | CZ23799A3 (es) |
| GB (1) | GB9615767D0 (es) |
| HU (1) | HUP9903619A3 (es) |
| IL (1) | IL128219A0 (es) |
| NO (1) | NO990322L (es) |
| NZ (1) | NZ333813A (es) |
| PL (1) | PL331426A1 (es) |
| TR (1) | TR199900140T2 (es) |
| WO (1) | WO1998004289A2 (es) |
| ZA (1) | ZA976593B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9612883D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| US6348455B1 (en) | 1998-11-23 | 2002-02-19 | Sepracor Inc. | Desmetylolanzapine compositions and methods |
| CA2352611A1 (en) | 1998-11-23 | 2000-06-02 | Sepracor Inc. | 2-hydroxymethylolanzapine compositions and methods |
| AU757870B2 (en) * | 1998-11-23 | 2003-03-06 | Sepracor, Inc. | Pharmaceutical compositions containing olanzapine-N-oxide |
| JP2003525865A (ja) | 1999-03-18 | 2003-09-02 | チルドレンズ・ホスピタル・リサーチ・ファウンデイション | 非定型抗精神病薬の投与による神経性過食症および関連摂食障害の治療方法 |
| JP2003500353A (ja) * | 1999-05-19 | 2003-01-07 | アストラゼネカ・アクチエボラーグ | 処置方法 |
| WO2005013969A1 (en) * | 2003-07-15 | 2005-02-17 | Janssen Pharmaceutica N.V. | Antipsychotic agent with socializing properties |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9500998D0 (sv) * | 1995-03-19 | 1995-03-19 | Haakan Wilhelm Wikstroem | New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics |
-
1996
- 1996-07-26 GB GBGB9615767.2A patent/GB9615767D0/en active Pending
-
1997
- 1997-07-22 JP JP10508522A patent/JP2000516924A/ja active Pending
- 1997-07-22 HU HU9903619A patent/HUP9903619A3/hu unknown
- 1997-07-22 CN CN97197977A patent/CN1230894A/zh active Pending
- 1997-07-22 BR BR9710568A patent/BR9710568A/pt not_active Application Discontinuation
- 1997-07-22 IL IL12821997A patent/IL128219A0/xx unknown
- 1997-07-22 NZ NZ333813A patent/NZ333813A/xx unknown
- 1997-07-22 KR KR1019997000622A patent/KR20000029564A/ko not_active Application Discontinuation
- 1997-07-22 TR TR1999/00140T patent/TR199900140T2/xx unknown
- 1997-07-22 AU AU42972/97A patent/AU725817B2/en not_active Ceased
- 1997-07-22 CA CA002261813A patent/CA2261813A1/en not_active Abandoned
- 1997-07-22 EP EP97918947A patent/EP0936924A2/en not_active Ceased
- 1997-07-22 CZ CZ99237A patent/CZ23799A3/cs unknown
- 1997-07-22 WO PCT/EP1997/004159 patent/WO1998004289A2/en not_active Application Discontinuation
- 1997-07-22 PL PL97331426A patent/PL331426A1/xx unknown
- 1997-07-24 AR ARP970103348A patent/AR008083A1/es not_active Application Discontinuation
- 1997-07-24 ZA ZA976593A patent/ZA976593B/xx unknown
- 1997-07-25 CO CO97042582A patent/CO5031292A1/es unknown
-
1999
- 1999-01-25 NO NO990322A patent/NO990322L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998004289A3 (en) | 1998-03-19 |
| IL128219A0 (en) | 1999-11-30 |
| NO990322L (no) | 1999-03-24 |
| CO5031292A1 (es) | 2001-04-27 |
| CZ23799A3 (cs) | 1999-06-16 |
| ZA976593B (en) | 1999-01-25 |
| AU725817B2 (en) | 2000-10-19 |
| AU4297297A (en) | 1998-02-20 |
| GB9615767D0 (en) | 1996-09-04 |
| KR20000029564A (ko) | 2000-05-25 |
| WO1998004289A2 (en) | 1998-02-05 |
| NZ333813A (en) | 2000-07-28 |
| HUP9903619A3 (en) | 2001-03-28 |
| HUP9903619A2 (hu) | 2000-10-28 |
| CA2261813A1 (en) | 1998-02-05 |
| PL331426A1 (en) | 1999-07-19 |
| EP0936924A2 (en) | 1999-08-25 |
| CN1230894A (zh) | 1999-10-06 |
| NO990322D0 (no) | 1999-01-25 |
| BR9710568A (pt) | 1999-08-17 |
| JP2000516924A (ja) | 2000-12-19 |
| TR199900140T2 (xx) | 1999-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120313T1 (el) | Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει βιταμινη d και κορτικοστεοειδες | |
| MX9301348A (es) | Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende. | |
| PA8435001A1 (es) | Derivados 6,6-heterobiciclicos sustituidos. | |
| AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
| ES2191192T3 (es) | Tienopirimidinas. | |
| ES2145774T3 (es) | Derivados de adenosina que tienen actividad agonista en a2. | |
| HN2002000275A (es) | Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados | |
| SV1998000029A (es) | Compuestos de pirazina ref. pg3186 | |
| AR021893A1 (es) | Compuesto de 2-fenil-1-(3,4-dihidroxi-5-nitrofenil)-1-etanona sustituida , su uso para la manufactura de un medicamento en el tratamiento de algunos trastornos del sistema nervioso central y periférico y composiciones farmacéuticas que las contienen | |
| CO5011096A1 (es) | Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs | |
| TR199901417T2 (xx) | Analjezik etkisi olan yeni bile�imler. | |
| AR008878A1 (es) | Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento. | |
| ES2139132T3 (es) | Composiciones farmaceuticas activas en la terapia de desordenes del sueño. | |
| MX9205681A (es) | Aminometil-cromanos, procedimiento para su fabricacion y medicamento que los contiene. | |
| UY26130A1 (es) | Compuestos para tratar la obesidad | |
| AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
| ES2171933T3 (es) | Derivados de androsteno. | |
| PA8457001A1 (es) | Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol | |
| ES2158597T3 (es) | Compuestos bioaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| ES2174337T3 (es) | Uso topico de los agonistas opioides kappa para el tratamiento del dolor ocular. | |
| AR008083A1 (es) | Composiciones farmaceuticas y el uso de compuestos para preparar medicamentos para tratar desordenes del snc. | |
| MX9301157A (es) | Derivados de bencimidazolona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| AR028772A1 (es) | 5-aminoalquil-pirazol[4,3-d] pirimidinas | |
| ES2052484T1 (es) | N-(5-tioxo-l-prolil)-l-cisteina, sus derivados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| UY26376A1 (es) | Combinaciones sinteticas de un antagonista de nk1 y un analogo estructural de gaba |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |